Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
4.300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2
Open
4.300
Bid (Size)
4.240 (5)
Ask (Size)
4.300 (1)
Prev. Close
4.300
Today's Range
4.300 - 4.300
52wk Range
3.140 - 21.88
Shares Outstanding
61,107,288
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MacroGenics to Participate in Upcoming Investor Conference
June 11, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Via
Benzinga
Performance
YTD
-57.76%
-57.76%
1 Month
-4.02%
-4.02%
3 Month
-69.33%
-69.33%
6 Month
-57.76%
-57.76%
1 Year
-20.07%
-20.07%
More News
Read More
Demystifying Macrogenics: Insights From 14 Analyst Reviews
May 24, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
May 25, 2024
Via
InvestorPlace
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics Stockholders and Encourages Investors to Contact the Firm
May 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX)
May 13, 2024
From
Kirby McInerney LLP
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
May 13, 2024
Via
Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
May 13, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Masters In Trading - Saturday, May 11
May 11, 2024
Via
Talk Markets
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
May 10, 2024
Via
Benzinga
Crude Oil Down 1%; Sweetgreen Shares Spike Higher
May 10, 2024
Via
Benzinga
Exposures
Fossil Fuels
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?
May 10, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
Nasdaq Moves Lower; US Consumer Sentiment Falls In May
May 10, 2024
Via
Benzinga
MacroGenics Shares Tumble After Reporting Adverse Events, Multiple Deaths In Cancer Drug Trial
May 10, 2024
Via
Benzinga
Topics
Death
Exposures
Death
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm
May 10, 2024
From
Schall Law
Via
GlobeNewswire
Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings
May 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Progyny (PGNY) Stock Down 27% Today?
May 10, 2024
Via
InvestorPlace
Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
May 10, 2024
Via
Benzinga
Why Is Macrogenics (MGNX) Stock Down 69% Today?
May 10, 2024
Via
InvestorPlace
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 10, 2024
Via
InvestorPlace
Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
May 10, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.